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Background: With drug treatment for dementia being of limited effectiveness, the role of primary prevention, in
particular the predictive value of modifiable cardiovascular disease risk factors, may warrant exploration. The
evidence base is, however, characterised by discordant findings and is modest in size. Accordingly, we examined
the association of modifiable cardiovascular disease risk factors with dementia death.
Design and methods: We pooled raw data from 10 UK general population-based prospective cohort studies
within the context of an individual participant meta-analysis.
Results: A total of 103,764 men and women were followed up for a mean of 8 years giving rise to 443 dementia-related
deaths and 2612 cardiovascular disease deaths. Cardiovascular disease mortality was, as anticipated, associated with the
full range of risk factors under study, including raised blood pressure, smoking, diabetes, physical inactivity. By contrast,
dementia death was related to very few of the cardiovascular disease risk factors: of those classified as modifiable, only
smoking was associated with a raised risk and higher levels of non-HDL with a lower risk.
Conclusions: In the present individual participant meta-analysis, there was limited evidence that cardiovascular disease
risk factors were related to dementia death.Background
The present and future social, economic, and disease bur-
den exacted by dementia is considerable and well docu-
mented. That drug treatment, even when implemented in
the early stages of the illness, is only symptomatic and of
limited effectiveness raises the need to identify primary
risk factors for dementia. If modifiable environmental in-
dices are shown to predict dementia, this could have im-
plications for control of the disease.
In particular, it has been posited that cardiovascular
disease (CVD) risk factors, many of which are modifi-
able, are linked to dementia development. The notion
that CVD and dementia or cognitive impairment may
have a shared aetiology was first advanced over four de-
cades ago [1]. However, in a recent consensus statement,* Correspondence: david.batty@ucl.ac.uk
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unless otherwise stated.an expert panel concluded that for Alzheimer’s Disease,
which represents up to 70% of all dementia cases [2],
there is insufficient evidence with which to form firm
conclusions about the influence of any modifiable envir-
onmental characteristic, including CVD risk factors [3].
Accordingly, we examined the association of a range of
established CVD risk factors with dementia death. To do
so, as we have done in different contexts [4-7], we present
a meta-analysis of individual-participant data from ten
UK population-based cohort studies. Taking this ap-
proach involves the pooling of raw data. In contrast
to the more traditional literature-based meta-analysis
in which investigators may have to exclude publica-
tions that do not present results in a standard manner,
the possibility of publication bias is reduced in an individ-
ual participant meta-analysis. Additionally, a literature
based meta-analysis cannot provide a consistent approach
to statistical control for plausible covariates. While the in-
dividual participant meta-analysis approach has been
taken for physiological risk factors in relation to somatic
disease outcomes [8,9], it is much less common in thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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study to date to explore the link between individual CVD
risk factors and dementia death and the first individual
participant meta-analysis. For the purposes of comparison,
we also report on the relation of the same collection of
risk factors with CVD mortality.
Methods
The Health Surveys for England (conducted 1998, 1999,
2003–6, and 2008) [10] and the Scottish Health Surveys
(1995, 1998, and 2003) [11] are UK-representative, re-
peat, cross-sectional, independent studies with on-going
mortality surveillance of their study members. Participants
gave informed consent; ethical approval was obtained
from the London Research Ethics Council. Participants
completed a questionnaire and took part in clinical exam-
ination. During both, CVD risk factors were assessed
using standard operating protocols as have been described
in detail [5,7].
Participants were linked to national mortality registers.
Causes of death (up to ten) recorded on certificates were
coded using the International Classification of Diseases,
Ninth (ICD-9) [12] and Tenth (ICD-10) [13] revisions.
Any mention of dementia death was identified using
codes 290.0 to 290.4, 294.9, 331.0 to 331.2, and 331.9 for
ICD-9 and F00, F01, F03, F09, G30 and G31 for ICD-10.
We have previously shown that in a cohort of Scottish
individuals with psychiatrist-confirmed dementia, almost
three quarters of those who subsequently died had de-
mentia recorded on their death certificate [14]. This sug-
gests that the use of dementia deaths data has some
validity.
Statistical analyses
Having ascertained that the proportional hazards as-
sumption had not been violated, we then used Cox pro-
portional hazards models [15] to compute study-specific
hazard ratios with accompanying 95% confidence inter-
vals for the association between each CVD risk factor and
dementia death. Preliminary results suggested that there
was no consistent evidence for differential risk factor-
dementia effects by gender; data for men and women were
therefore pooled with hazard ratios sex-adjusted.
The study-specific effect estimates and their standard
errors were pooled using a random effects meta-analysis.
In contrast to a fixed-effects meta-analysis, a random-
effects approach allows for variation in observed risk fac-
tor–disease estimates across studies which occur because
of real differences in the association in each study and/or
sampling variability. We chose a priori a random-effects
technique for two reasons. First, many of the CVD risk
factors featured in the present report (raised blood pres-
sure, obesity, physical activity, smoking and so on) have
been the subject of primary care-based modificationduring the period of follow-up of the included studies. De-
pending on the era of the study in question, this may have
had an impact on the risk factor–disease associations
under scrutiny. Second, there have now been a series of
papers from this collaboration in which the outcomes of
interest have been the same as the present analyses–CVD
[5,7] and dementia [4-6]–although the predictor variables
have differed. That these existing results suggest evidence
of heterogeneity across studies, provided us with a second
reason to utilise the random-effects approach.
Heterogeneity in the effect estimates between studies
was examined by computing an I2 statistic, which indi-
cates the proportion of the total variation in the estimates
that is due to between-studies variation. Calendar time
(months) was the time scale. We censored study members
at death or the end of follow-up (15th February 2011),
whichever came first.
Results
From an initial sample of 122,060 participants, 18,296
did not consent to mortality record linkage or, if they
did, had missing survival or mortality data, giving a max-
imum analytic sample of 103,764 (55% female, mean age
47.3 years, SD = 18.1, range = 16-102). Of 7933 deaths oc-
curring during a mean (SD) follow up of 7.9 (3.8) years,
443 were dementia-related and 2612 were cardiovascular
disease-related. With dementia as the outcome of interest,
the I2 statistic varied between 0% and 76.4% depending on
the CVD risk factor in question. This provided post hoc
justification of our random-effects approach to the meta-
analysis.
Table 1 depicts the association of fourteen CVD risk
factors with dementia death and CVD death risk. Im-
portantly, known risk factor–CVD relationships were all
replicated in the present analyses. Thus, conventionally
unfavourable levels of blood pressure and total choles-
terol, high body mass index, smoking, diabetes and low
physical activity were associated with higher CVD death
rates, although effect of systolic hypertension did not
reach statistical significance.
By contrast, dementia was associated with very few of
the CVD risk factors. Being male, older, and smoking
were shown to confer an increased risk of dementia
death, while higher non-HDL cholesterol and obesity
were both associated with protection. The result for
obesity was surprising. Speculating that this could be as-
cribed to reverse causality–dementia influencing the
risk factor rather than the converse–led us to drop de-
mentia deaths occurring in the first five years of follow-up
(‘left’ censoring) and repeat our analyses (a standard ana-
lytical procedure in epidemiology). This attenuated the
obesity–dementia association to the null (HR; 95% CI:
0.88; 0.62-1.26 based on 214 dementia deaths in 70391
men and women).
Table 1 Age- and gender-adjusted hazard ratios (95% confidence intervals) for the relation of individual cardiovascular
disease risk factors with dementia death and cardiovascular disease death: individual participant meta-analysis of ten
general population-based cohort studies
Risk factor Comparison Cardiovascular disease Dementia
Deaths Nk HR (95% CI) P-value Deaths Nk HR (95% CI) P-value
Age Per 5 yr increase 2612 103764 1.78 (1.74, 1.82) <0.001 443 103764 2.42 (2.29, 2.56) <0.001
Gender Female vs. male 2612 103764 0.60 (0.53, 0.68) <0.001 443 103764 0.78 (0.65, 0.95) 0.01
Marital status See footnotea 990 61171 1.34 (1.00, 1.80) 0.049 156 61171 0.94 (0.58, 1.53) 0.81
Occupational social class Non-manual vs. manual 2486 97455 1.36 (1.18, 1.57) <0.001 424 97455 1.11 (0.86, 1.43) 0.42
Educational attainment Left school ≤ 15 yr vs. older 2610 103680 1.38 (1.25, 1.52) <0.001 443 103680 1.18 (0.95, 1.45) 0.13
Hypertension See footnoteb 1600 63989 2.10 (1.83, 2.41) <0.001 283 61751 0.96 (0.71, 1.30) 0.79
Systolic blood pressure See footnotec 1600 63989 1.08 (0.90, 1.30) 0.39 283 61751 0.87 (0.68, 1.11) 0.27
Diastolic blood pressure See footnoted 1600 63989 1.50 (1.31, 1.71) <0.001 283 61751 1.02 (0.69, 1.50) 0.92
Uncontrolled hypertension See footnotee 803 46410 2.55 (2.08, 3.12) <0.001 128 44626 0.88 (0.60, 1.29) 0.52
Smoking status Current smoker vs. other 2606 103282 1.86 (1.62, 2.15) <0.001 443 103282 1.75 (1.33, 2.29) <0.001
Current drinker Current vs. never/formerf 2610 103072 0.77 (0.64, 0.94) 0.01 443 103072 0.85 (0.67, 1.07) 0.17
High total cholesterol See footnoteg 1424 55355 1.30 (1.04, 1.62) 0.02 233 53375 0.88 (0.67, 1.15) 0.34
Non-HDL cholesterolh Per SD (1.2 mmol/L) rise 1135 49562 1.06 (1.00, 1.19) 0.04 200 42271 0.82 (0.70, 0.96) 0.01
Serum C-reactive protein Per SD (6.7 mmol/L) rise 1022 39352 1.14 (1.07, 1.21) <0.001 191 37439 1.03 (0.93, 1.15) 0.56
Body mass index ≥ 30 kg/m2 vs. < 30 1952 90978 1.24 (1.12, 1.37) <0.001 322 90978 0.71 (0.53, 0.97) 0.03
Diabetes status Yes vs. noi 2605 100639 1.97 (1.65, 2.35) <0.001 441 100639 1.03 (0.73, 1.46) 0.85
Physical inactivity < 5 sessions/week vs. ≥ 5j 2404 95426 1.63 (1.40, 1.89) <0.001 401 95426 1.17 (0.72, 1.91) 0.52
Longstanding illness Any vs. none 2612 103742 1.91 (1.74, 2.09) <0.001 443 103742 1.10 (0.90, 1.36) 0.35
aSingle, separated, divorced, or widowed vs. married, civil partnership or cohabiting. bSystolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or
taking antihypertensive treatment (NICE guidance) vs. other. cSystolic blood pressure ≥ 140 mmHg vs other. dDiastolic blood pressure ≥ 90 mmHg vs other. eDespite
antihypertensive medication, either systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or both vs. normotensive individuals. fCurrent drinkers
(any amount) compared to never- or ex-drinkers. gSerum total cholesterol ≥ 6.2 mmol/L or on lipid-lowering treatment versus other. hNon-HDL cholesterol (calculated by
subtraction of HDL-C from total cholesterol, yielding a measure that encompasses low-, intermediate-, and very-low-density lipoprotein cholesterol). Hazard ratios are per
standard deviation increase (disadvantage). iDiabetes denoted by doctor-diagnosed diabetes, longstanding illness (diabetes), HbA1c ≥ 6.0%, and/or diabetes medication.
jFewer than five average weekly sessions of moderate to vigorous physical activity including domestic (walk/domestic 30 mins+, sports/exercise 15 mins+) compared to
five or more (UK government recommendations). kSome cohort studies were excluded from specific risk factor analyses owing to the absence of any dementia deaths.
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ated with dementia death in the above age- and gender-
adjusted analyses we carried out mutual adjustment. Based
on 322 dementia deaths in the 60625 men and women
with complete data, and using the same comparators, our
results were essentially unchanged: age (2.53; 2.35, 2.73),
gender (0.80; 0.64, 1.00), smoking (1.60; 1.15, 2.22) and
body mass index (0.72; 0.53, 0.97).
Discussion
In the present study-to our knowledge, the first meta-
analysis in the field-there was limited evidence that CVD
risk factors were related to an increased occurrence of de-
mentia death. The few positive results included higher
age, male sex, smoking and, surprisingly being non-obese,
the last finding disappearing when taking into account re-
verse causality. That established risk factor–CVD associa-
tions were confirmed, gives us some confidence in the
results for dementia.
While our dataset has its strengths–its size and the com-
prehensive set of CVD risk factors variables assessed–it isof course not without its shortcomings. While we had
data on a series of health behaviours (smoking, alco-
hol intake, and exercise) we did not have information
on dietary characteristics which may be linked to de-
mentia risk. Additionally, comprising a series of subtypes
(Alzheimer’s disease, vascular dementia, AIDS dementia,
and so on), dementia is not a single nosological entity.
As it is likely that these subtypes do not have a unify-
ing aetiology, using a composite dementia endpoint may
mask some subtype-specific associations with CVD risk
factors. It is also the case, however, that, with the ma-
jority of dementias being Alzheimer’s, our findings
are most applicable to this dementia presentation. Fi-
nally, our outcome of interest was dementia death, not
incidence; as such, our exposures are more distant from
dementia event. This notwithstanding, as described, in a
separate study [14], we found that, in a cohort of pa-
tients diagnosed with probable Alzheimer’s disease, of
the 502 who had died after 11 years of follow-up,
72% had their dementia recorded as either a primary
or contributing cause on their death certificate. This
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dementia incidence.
Taking these results together, there was limited evidence
that these CVD risk factors were related to the occurrence
of dementia death in the current study.
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